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Abstract 
Background: Preeclampsia is a multi-organ system disorder that occurs after the 20th week of gestation in preg-
nancy and is characterized by hypertension and proteinuria. In Africa more than 270,000 women die from maternal 
deaths, worldwide approximately 76,000 women and 500,000 babies die yearly due to preeclampsia. It affects about 
8–10 % of all pregnancies. Studies have shown that up to 77 % women affected with preeclampsia lack knowledge 
about preeclampsia, and therefore cannot take preventative measures. The aim of study is to evaluate the outcomes 
and quality of care given to preeclamptic patients treated in Dilla University Referral Hospital.
Methods: The study is a retrospective, hospital based study. One hundred and seventy two records of women were 
retained for final study out of 7702 patients from January 2009 to December 2012.
Results: The incidence rate of preeclampsia in Dilla University Referral Hospital was found to be 2.23 %. The common 
mean ages found to be affected for preeclampsia were 19.2, 22.5 and 27.8 and 31.5 with a trend towards increasing 
severity with younger age population.
Conclusion: A guideline on the management and prevention of preeclampsia needs to be produced for Ehiopia.
Keywords: Preeclampsia, Hypertension, Proteinurea, Quality care, Neonatal morbidity, Maternal morbidity, Ethiopia
© 2015 Vata et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Preeclampsia has been a major cause of poor result in 
pregnancy and the category “hypertensive diseases of 
pregnancy” and is a leading cause of maternity in Africa 
[1]. It is a common pregnancy disorder that correspond 
one out of the three cases i.e. obstetric morbidity, hyper-
tension and/or proteinuria [2, 3]. Preeclampsia is the 
most public hazardous pregnancy complication affect-
ing mother as well as foetus [4]. It is assorted with an 
increased risk factor of cardiovascular diseases and type 
II diabetes in later life cycle of mother [5]. Preeclampsia 
is responsible for approximately 50,000 maternal deaths 
worldwide annually out of which 25  % of cases are due 
to Intra Uterine Growth Restrictions (IUGR) and 15  % 
are outcome of preterm birth in developed countries [4]. 
However, there is no known cure for preeclampsia apart 
from delivery of the baby and the placenta. Accordingly, 
early diagnosis of preeclampsia and close observation are 
assertive for controlling preeclampsia during pregnancy.
The strategy employed by high-income countries have 
successfully reduced both the incidence of eclampsia and 
the mortality associated with it by almost 90 %, utilizing a 
combination of early detection during Antenata Care and 
increased access to hospital care for women who develop 
preeclampsia [6]. Parallel reduction mostly in rural China 
and Srilanka suggest that this framework for routinely 
screening pregnant women for hypertension and pro-
teinuria, treating severe preeclampsia patients with anti-
hypertensive and anti-convulsant drugs and, if necessary, 
ending the pregnancy by inducing childbed or dealing 
caesarean delivery can work as good model especially in 
low-income countries [7]. In Africa, preeclampsia occurs 
in 10 % of pregnancies, which is significantly higher than 
the global average of approximately 2  % [1]. Roughly, 
four in every hundred women develops problem of high 
blood pressure and leaky kidney during pregnancy. Black 
women are more prone to get high blood pressure and 
preeclampsia than white women [8]. The saving mother 
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report on confidential enquiry in maternal death from 
South Africa (1999–2001) reported poor quality of care 
being a major contributor to maternal death from preec-
lampsia. The deaths were attributed to lack of transport 
(11–20  %); lack of appropriately trained medical staff 
(up to 55 %) and failure in recognize patient’s problems 
(12  %). In addition to this, 64  % of the preeclampsia 
women who died in 1998 and 55.5 % of those who died in 
2001 had received sub-standard management [9]. There 
are very few studies that report the prevalence of preec-
lampsia in Africa [1, 10, 11]. According to a  2010 UN 
report, Ethiopia is one of the five countries that together 
account for 50 percent of the world’s maternal deaths and 
rural areas mostly contribute to maternal deaths [12]. 
In 2011, the country recorded 676 maternal deaths for 
every 100,000 live births, up from 673 in 2005. Unfortu-
nately, the reason for such death is still unclear. There is 
no in-depth study so far done in Ethiopia, mostly in Dilla 
region, which looks at the extent of “confirmed” preec-
lampsia and its contribution to the maternal and perina-
tal morbidity and mortality.
The objective of this study is to evaluate the outcome 
and quality of care given to preeclampsia patients treated 
in Dilla University Referral Hospital of Ethiopia within 




Retrospective study was conducted from January 2009 
to December 2012 to assess the prevalence of eclampsia 
among patients diagnosed at Dilla University Referral 
Hospital. Dilla town is the capital of Gideon Zone situ-
ated in SNNPR state with a total area of 1347.4 square 
kilometres and encompasses two cities administrations 
with six woredas. It is located at an altitude of 1300–
3000  m above sea level and the climate favours desert 
conditions. The total population is 94,189 out of which 
46,058 (49.9 %) are males and 48,131 (50.1 %) are females 
[13].
The Dilla University Referral Hospital is the only ter-
tiary care institute that received referral of high and low 
risk pregnancies from village hospitals, general practi-
tioners and specialist obstetricians in addition to their 
own patients. Different senior medical superintendents, 
19 physicians, 53 nurses lead the referral hospital with a 
bed capacity of 156.
Ethical consideration and source of data
It was believed that the study will contribute to the pro-
vision of quality care to preeclamaptic women, permis-
sion to conduct the study was granted by the Higher 
Degree Committee of the University Referral Hospital. 
After obtaining the consent from higher authorities the 
data was collected from register book. As the study con-
sisted entirely of confidential record review, no informed 
consent was deemed necessary. Precautions were taken 
to keep personal identifier data separate from data col-
lected using confidential study numbers. Information 
on demographic, clinical, laboratory and management 
of all preeclamptic patients and their babies who were 
admitted to referral hospital during the study period was 
retrieved from the maternity admission registers, deliv-
ery books and operation books.
Sampling method and size
From January 2009 to December 2012 approximately 
there were 7702 patients admitted in gynaecology ward 
of Dilla University Referral Hospital. Women with a diag-
nosis or listed complications of preeclampsia or eclamp-
sia, or symptoms associated with preeclampsia (i.e. 
hypertension, convulsions, oedema, etc.) were selected 
from the maternity and theatre register books during 
the study period. The latter (symptoms) were included to 
improve complete case finding. These files were system-
atically retrieved and reviewed for the following inclusion 
criteria {standard definition for diagnosis of preeclamp-
sia: blood pressure >140/90, proteinuria >  +1, with or 
without oedema} [14]. Due to potential loss or unavail-
ability of older records, cases were selected in backward 
fashion from three years of hospital maternity and thea-
tre registers and records until the desired sample size 
was obtained. Those with symptoms but not confirmed 
diagnosis and others who did not registered according to 
criteria were excluded.
Quality care for patients
The quality of care was measured based on the basis of 
technical care received by study subjects during their stay 
in the hospital. The quality of care that has been given to 
the patients at different levels (during ante partum, stages 
of labour, and when complication were observed) includ-
ing appropriateness of medications and mode of delivery 
was measured against the standard management protocols 
for preeclampsia as recommended by the South African 
National Department of Health and National Committee 
for the Confidential Enquiry into Maternal Deaths [15].
A total of 172 cases confirmed of preeclampsia were 
included during the study period to demonstrate neona-
tal and maternal outcomes. The salient features included 
name and age of patients, obstetric history, present ill-
ness, the findings of general physical examination and 
systemic examination specially abdominal and vaginal 
examination. Patients were assessed on the basis of his-
tory, clinical examination, ultrasound and laboratory 
investigations during the study interval.
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Statistical interference of data
The data was processed using Statistical Software Pack-
ages for Social Science (SPSS) by using Chi square test. 
P < 0.05 was considered statistically significant.
Results
Incidence of preeclampsia
Generally, 7702 patients were admitted to gynecology 
ward out of which 172 admissions were preeclamptic. On 
the basis of this data the incidence rate of preeclampsia in 
Dilla University Referral Hospital was found to be 2.23 %. 
Out of 172 preeclmaptic women with the diagnosis of 
preeclampsia, 113 (65.68  %) had mild preeclampsia, 30 
(17.42 %) posses severe preeclampsia and remaining i.e. 
29 (16.83 %) showed eclampsia (Fig. 1).
Socio‑demographic data
The common mean ages found to be affected for preec-
lampsia were 19.2, 22.5 and 27.8 and 31.5. Among 172 
suffered patients, 81 (47.09  %) were in mean age group 
of 19.2. While, 42 (24.41  %) belongs to 22.5 mean age 
group. 29 patients (16.86 %) out of 172 suffered women 
represent to 27.8 mean group of age and the rest i.e. 20 
(11.63 %) has 31.5 mean age group (Fig. 2). These mean 
differences were significant (P  =  0.0005, P  =  0.0023, 
P  =  0.0032, P  =  0.0046 for 19.2, 22.5, 27.8, 31.8 mean 
age group respectively) and suggested a trend towards 
increasing severity with younger age population. Eth-
nically out of 172 patients 61 (35.46  %), 42 (24.41  %), 
29 (16.86 %), 21 (12.20 %), 19 (11.04 %) were belongs to 
Amhara, Sidama, Welayata, Oromo and Gurage respec-
tively (Table 1).
Quality control of patients from Dilla University Referral 
Hospital
On the basis of Dilla University Referral Hospital, length 
of stay of suffered patients were 1–5 days for 79 (45.93 %), 
6–10 days for 54 (31.39 %), 11–15 days for 23 (13.37 %), 
16–20 days for 11 (6.39 %) and 21–25 days for 5 (2.90 %) 
of all the preeclamptic women. The mean hospital stay 
was 6.0 days for the mild preeclamptic, 8.3 days for the 
severe preeclamptic and 9.1  days for that of eclamp-
tic. On admission to hospital 80 (46.51 %) out of all the 
patients had no physical complaints, while 51 (29.65  %) 
had a headache, 12 (6.97 %) epigastric pain, 15 (8.72 %) 
convulsion, 8 (4.65 %) blurred vision and 6 (3.48 %) vagi-
nal bleeding (Table 2).
Gestational age on admission to referral hospital was 
found to be 6 (3.48  %) at 22–25  weeks, 20 (11.62  %) at 
26–30 weeks, 63 (36.62 %) at 31-35 weeks, 80 (46.51 %) 
at 36–40 weeks and 3 (1.744 %) at 41+ weeks. The mean 
gestational age for the mild preeclamptic was 34.8 weeks, 
33.1  weeks for severe preeclamptic and for eclamptic it 
was 35.3 (Table 2).
One hundred fifty three (88.93 %) of the preeclamptic 
women of the study group gave birth by means of cae-
sarean section and nineteen (11.07 %) vaginally (Table 2). 
The indication for caesarean deliveries were: 53 (34.64 %) 
mild preeclampsia, 42 (27.45  %) severe preeclampsia, 
27 (17.64  %) foetal distress, 13 (8.49  %) eclampsia, 10 
(6.43  %) previous caesarean section.  5 (3.26  %) failed 
induction, 2 (1.30  %) abruptio placenta, and 1(0.65  %) 
intra uterine foetal death (IUFD) (Table 2).
The results regarding the perinatal conditions showed 
a prevalence of 90.69 % of live births. Low birth weight 
(<2.5 kg) was seen in 13.37 % of cases. There were 9.30 % 
of stillbirths (Table 2). Perinatal mortality rate increased 
as severity of preeclampsia increased. Neonatal intensive 
care unit admissions were seen in 19.4 % of cases.
Discussion
Anticipation of preeclampsia is widely depends on detec-
tion of risk factors, measurement of arterial pressure, 
proteinuria and edema. The importance of anticipating 
which women will develop preeclampsia lies in the need 
of particular medical care and preventive measures that 
might prolong the pregnancy and reduced the maternal 
and foetal risks [16]. Majority of preeclampsia related 
deaths in the low income countries widely occurs in 
community, thus it must be focussed at this level. Espe-
cially in Africa, preeclampsia occurs in 10 % of pregnan-
cies, which is significant higher than the global average 
of approximately 2 % [1]. It is important that preventive 
strategies must be applied to every pregnant woman 
since it is behind the scope to predict which women will 
develop preeclampsia. Three primary delays can lead 
to increased in relative incidence of maternal mortality 
from preeclampsia includes: late in decision making to 
attempt, delay in approaching health facility and detain in 
health service provision. The prevalence of preeclampsia 
Fig. 1 Distribution and frequency of different categories of pree-
clmaptic cases of Dilla University Referral Hospital from January 2009 
to December 2012
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observed in the proposed study is in the agreement with 
the data found in African countries, where approximately 
10 % of total pregnancies cases are diagnose with preec-
lampsia. The frequency of preeclampsia which is around 
2.23  % almost equivalent to the expected value of 2  % 
quoted in global literature [1].
Our study demonstrates that there was no significant 
maternal mortality observed during the study period. The 
neonatal mortality was also low in comparison to mater-
nal mortality (Table  2). It was also found that approxi-
mately 925 of all the preeclamptic patients received 
anti-hypertension drugs. Some of interesting findings 
are encouraging when it was noticed that: there was no 
significant difference in the management of different cat-
egories of preeclampsia studied; caesarean section was 
extremely high (88.93  %); use of magnesium sulphate 
as prophylaxis was very low (only 15 % of severe preec-
lampsia cases received magnesium sulphate) (result not 
shown).
Out of 173 women, 152 (87.86 %) preeclamptic women 
in the study group were in the range of age group of 
16-30 years indicating younger women are more prone to 
preeclampsia in comparison to elder one. Results of ages 
are correlates to the studies of Moodley and Mashioane 
[17] and Brown and Buddle [18]. Significant differences in 
the mean age of different categories of preeclampsia sug-
gest a trend towards increasing severity with younger age 
which also corresponds to the findings of Hall et al. [19] 
where younger women are at higher risk for developing 
Fig. 2 Age group of preclamptic cases registered in Dilla University Referral Hospital from January 2009 to December 2012. Values indicated are 
the distribution of preeclamptic patients to different age groups noted in Dilla University Referral Hospital. Error bar represents standard deviation. 
***Highly significant; **moderate significant; *less significant
Table 1 Distribution of different categories of preeclamp-
sia among different ethnic category of Dilla region
Values indicated are the distribution of preeclamptic patients to different ethnic 
group. Values in parenthesis indicates the frequency of percentage of three 
different categories of preeclampsia






Amhara 44 (25.58 %) 11 (06.39 %) 06 (03.48 %) 61 (35.46 %)
Sidama 32 (18.60 %) 06 (03.48 %) 04 (02.32 %) 42 (24.41 %)
Welayata 17 (09.88 %) 10 (05.81 %) 02 (01.16 %) 29 (16.86 %)
Oromo 09 (05.23 %) 02 (01.16 %) 10 (05.81 %) 21 (12.20 %)
Gurage 11 (06.39 %) 01 (00.58 %) 07 (04.06 %) 19 (11.04 %)
Total 113 (65.68 %) 30 (17.42 %) 29 (16.83 %) 172
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eclampsia. The decrease incidence of preeclampsia by 
ethnicity from Amhara to Gurage could be due to the 
distribution of population among Dilla region. Similarly 
when ethnicity is compared by colour Amhara, Sidama 
amd Welayata which are black in colour contribute more 
to preeclampsia (76.73 %) compare to other ethnic group 
(Table  1). Thus our studies indicates that being black is 
a risk factor for preeclampsia. Apart from above results 
Table 2 Quality control background characteristics of  172 preeclamptic patients admitted to  Dilla University Referral 
Hospital
Values indicated are the distribution of preeclamptic patients to different quality control given to patients admitted to Dilla University Referral Hospital. Values in 
parenthesis indicates the frequency of percentage of three different categories of preeclampsia
Number of patients Total
Mild preeclampsia Severe preeclampsia Eclampsia
Stay in Hospital
 1–5 days 67 (38.95 %) 08 (04.65 %) 04 (02.32 %) 79 (45.93 %)
 6–10 days 36 (20.93 %) 13 (07.55 %) 05 (02.90 %) 54 (31.39 %)
 11–15 days 07 (04.06 %) 04 (02.32 %) 12 (06.97 %) 23 (13.37 %)
 16–20 days 02 (01.16 %) 04 (02.32 %) 05 (02.90 %) 11 (06.39 %)
 21–25 days 01 (00.58 %) 01 (00.58 %) 03 (01.74 %) 05 (02.90 %)
 Total 113 (65.68 %) 30 (17.42 %) 29 (16.83 %) 172
Complaints
 No physical complaints 71 (41.27 %) 06 (03.48 %) 03 (01.74 %) 80 (46.51 %)
 Headache 34 (19.76 %) 15 (08.72 %) 02 (01.16 %) 51 (29.65 %)
 Epigestric pain 02 (01.16 %) 06 (03.48 %) 04 (02.32 %) 12 (06.97 %)
 Convulsion 02 (01.16 %) 01 (00.58 %) 12 (06.97 %) 15 (08.72 %)
 Blurred vision 03 (01.74 %) 01 (00.58 %) 04 (02.32 %) 08 (04.65 %)
 Vaginal bleeding 01 (00.58 %) 01 (00.58 %) 04 (02.32 %) 06 (03.48 %)
 Total 113 (65.68 %) 30 (17.42 %) 29 (16.83 %) 172
Gestation week
 22–25 03 (01.74 %) 02 (01.16 %) 01 (00.58 %) 06 (03.48 %)
 26–30 17 (09.88 %) 01 (00.58 %) 02 (01.16 %) 20 (11.62 %)
 31–35 36 (20.93 %) 13 (07.55 %) 14 (08.13 %) 63 (36.62 %)
 36–40 55 (31.97 %) 13 (07.55 %) 12 (06.97 %) 80 (46.51 %)
 41 and above 02 (01.16 %) 01 (00.58 %) 00 (00.00 %) 03 (01.74 %)
 Total 113 (65.68 %) 30 (17.42 %) 29 (16.83 %) 172
Mode of delivery
 SVD 14 (08.18 %) 04 (02.32 %) 01 (00.58 %) 19 (11.04 %)
 C-Section 71 (41.27 %) 61 (35.46 %) 21 (12.20 %) 153 (88.95 %)
 Total 85 (49.41 %) 65 (37.79 %) 22 (12.79 %) 172 (100 %)
Indication of C-section
 Mild preeclampsia 22 (14.37 %) 24 (15.68 %) 07 (04.57 %) 53 (34.64 %)
 Severe preeclmapsia 22 (14.37 %) 12 (07.84 %) 08 (05.22 %) 42 (27.45 %)
 Foetal distress 13 (08.49 %) 12 (07.84 %) 02 (01.30 %) 27 (17.64 %)
 Eclampsia 05 (03.26 %) 07 (04.57 %) 01 (00.65 %) 13 (08.49 %)
 Previous C-section 05 (03.26 %) 03 (01.74 %) 02 (01.30 %) 10 (06.53 %)
 Failed induction 02 (01.30 %) 02 (01.30 %) 01 (00.65 %) 05 (03.26 %)
 Abruptio placenta 01 (00.65 %) 01 (00.58 %) 00 (00.00 %) 02 (01.30 %)
 IUFD 01 (00.65 %) 00 00 (00.00 %) 01 (00.65 %)
 Total 71 (46.40 %) 61 (39.86 %) 21 (13.72 %) 153 (100 %)
Neonatal variables
 Live birth 13 (7.55 %) 119 (69.18 %) 24 (13.95 %) 156 (90.69 %)
 Still Birth 02 (1.16 %) 11 (6.39 %) 3 (1.74 %) 16 (9.30 %)
 Low birth weight 5 (2.90 %) 12 (6.97 %) 6 (3.48 %) 23 (13.37 %)
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there was no significant difference (P  =  0.613) in the 
mean hospital stay between three categories of preec-
lampsia of our study. This indicates that there was lit-
tle distinction in the management of difference types of 
preeclampsia.
Different studies have shown that prolongation of ges-
tation in uncomplicated preeclampsia enhances foetal 
maturity [20]. Similarity of the mean hospital stay and 
almost universal delivery by caesarean among different 
patients in this study indicates that there was not proper 
management practice in Dilla University Referral Hospi-
tal. Most of the mild preeclampsia reports can be man-
aged expectantly as frequent recommended management 
of mild preeclampsia [21] and in return may reduced 
Intensive Care Unit (ICU) admission of neonates. How-
ever, other studies also shown that aggressive manage-
ment comparison with expectant management results in 
equivalent maternal morbidity, fewer small for gestation 
age infants and marks the seriousness for neonatal mor-
bidity [22].
In the end the findings indicates that the management 
of preeclampsia in Dilla University Referral Hospital 
lacks specificity for different categories of preeclampsia. 
This could be because of lacks of guidelines in the man-
agement of preeclampsia to assist clinicians to make crit-
ical decision when they are challenge by different severity 
of diseases. Further research on risk factors may suggest 
effective ways to prevent preeclampsia.
Conclusions
The results presented are the systematic information 
for care given to preeclamptic cases was not totally in 
line with the international or South African regional 
guidelines of preeclampsia management. A guideline 
on the management and prevention of preeclamp-
sia needs to be produced for Ehiopia, and further 
research on risk factors and on cost effectiveness of 
premature termination of pregnancy needs to be look 
seriously.
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